Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities.

Front Neurol · 2021 · PMC8165183 · PMID 34079516

Europe PMC DOI

hedged sentence

0.2900

closest p · 5.8× alpha

0.2900

boldest claim

The sentences

did not reach statistical significancep = 0.29not close (p > 0.1)

Teriflunomide numerically reduced the risk of clinical relapse by 34% relative to placebo, but this did not reach statistical significance ( p = 0.29).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.